AIVITA Biomedical CEO Hans Keirstead Named to “20 in 2020” by Consulate General of Canada for Contributions to COVID-19 Research

IRVINE, Calif.--(BUSINESS WIRE)--AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, announced that Hans Keirstead, Ph.D., chairman and chief executive officer, has been named to the “20 in 2020” by the Consulate General of Canada. This year the list recognizes 20 individuals for contributions to the COVID-19 pandemic response. “The global response to COVID-19 has been unprecedented, with researchers w

Click to view original post